An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi

Journal of Immunology

Volumn 163, Issue 10, 1999, Pages 5566-5573

  Liang, Fang Ting ^a   Alvarez, Alida L ^a   Gu, Yan ^a   Nowling, Jena M ^a   Ramamoorthy, Ramesh ^a   Philipp, Mario T ^a  

^a TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; EPITOPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; BORRELIA BURGDORFERI; BORRELIA INFECTION; CONTROLLED STUDY; EPITOPE MAPPING; HUMAN; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL PROTEINS; BORRELIA BURGDORFERI GROUP; CONSERVED SEQUENCE; GENOTYPE; HUMANS; IMMUNODOMINANT EPITOPES; LIPOPROTEINS; MACACA MULATTA; MICE; MICE, INBRED C3H; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY;

EID: 0033571071     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Borst, P., and G. A. M. Cross. 1982. Molecular basis for trypanosome antigenic variation. Cell 29:291.
2. Borst, P., W. Bitter, P. A. Blundell, I. Chaves, G. A. M. Cross, H. Gerrits, F. van Leeuwen, R. McCulloch, M. Taylor, and G. Rudenko. 1998. Control of Vsg gene expression sites in Trypanosoma brucei. Mol. Biochem. Parasitol. 91: 67.
3. Pays, E., and D. P. Nolan. 1998. Expression and function of surface proteins in Trypanosoma brucei. Mol. Biochem. Parasitol. 91:3.
4. Hagblom, P., E. Segal, E. Billyard, and M. So. 1985. Intragenic recombination leads to pilus antigenic variation in Neisseria gonorrhoeae. Nature 315:156.
5. Pearce, W. A., and T. M. Buchanan. 1978. Attachment role of gonococcal pili. J. Clin. Invest. 61:931.
6. Stoenner, H. G., T. Dodd, and C. Larsen. 1982. Antigenic variation of Borrelia hermsii. J. Exp. Med. 156:1297.
7. Meier, J. T., M. I. Simon, and A. G. Barbour. 1985. Antigenic variation is associated with DNA rearrangements in a relapsing fever Borrelia. Cell 41:403.
8. Zhang, J. R., J. M. Hardham, A. G. Barbour, and S. J. Norris. 1997. Antigenic variation in Lyme disease Borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89:275.
9. Zhang, J. R., and S. J. Norris. 1998. Genetic variation of the Borrelia burgdorferi gene vlsE involves cassette-specific, segmental gene conversion. Infect. Immun. 66:3698.
10. Reinitz, D. M., B. D. Aizenstein, and J. M. Mansfield. 1992. Variable and conserved structural elements of the trypanosome variant surface glycoprotein. Mol. Biochem. Parasitol. 51:119.
11. Forest, K. T., S. L Bernstein, E. D. Getzoff, M. So, G. Tribbick, H. M. Geysen, C. D. Deal, and J. A. Tainer. 1996. Assembly and antigenicity of the Neisseria gonorrhoeae pilus mapped with antibodies. Infect. Immun. 64:644.
12. Restrepo, B. I., T. Kitten, C. J. Carter, D. Infante, and A. G. Barbour. 1992. Subtelomeric expression regions of Borrelia hermsii linear plasmids are highly polymorphic. Mol. Microbiol. 6:3299.
13. Borst, P. 1991. Molecular genetics of antigenic variation. Immunol. Today. 12: A29.
14. Zhang, J. R., and S. J. Norris. 1998. Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi. Infect. Immun. 66:3689.
15. Kawabata, H., F. Myouga, Y. Inagaki, N. Murai, and H. Watanabe. 1998. Genetic and immunological analyses of Vls (VMP-like sequences) of Borrelia burgdorferi. Microb. Pathog. 24:155.
16. Hopp, T. P., and K. R. Woods. 1981. Prediction of protein antigenic determinants from amino acid sequences. Proc. Natl. Acad. Sci. USA 78:3824.
17. Philipp, M. T., M. K. Aydintug, R. P. Bohm, Jr., F. B. Cogswell, V. A. Dennis, H. N. Lanners, R. C. Lowrie, Jr., E. D. Roberts, M. D. Conway, M. Karaçorlu, et al. 1993. Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infect. Immun. 61:3047.
18. Ramamoorthy, R., L. Povinelli, and M. T. Philipp. 1996. Molecular characterization, genomic arrangement and expression of bmpD, a new member of the bmp class of genes encoding membrane proteins of Borrelia burgdorferi. Infect. Immun. 64:1259.
19. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
20. Zhang, J., and T. L. Madden. 1997. PowerBLAST: a new network BLAST application for interactive or automated sequence analysis and annotation. Genome Res. 6:649.
21. Barony, G., and R. B. Merrifield. 1980. The Peptides: Analysis, Synthesis, and Biology. Academic Press, New York, p. 3.
22. Centers for Disease Control and Prevention. 1997. Case definition for infectious conditions under public health surveillance. MMWR Morb. Mortal. Wkly. Rep. 46:20.
23. Nowling, J. M., and M. T. Philipp. 1999. Killing of Borrelia burgdorferi by antibody elicited by OspA vaccine is inefficient in the absence of complement. Infect. Immun. 67:443.
24. Hopp, T. P. 1993. Retrospective: 12 years of antigenic determinant predictions, and more. Pept. Res. 6:183.
25. Schoenfeld, R., B. Araneo, Y. Ma, L. M. Yang, and J. J. Weis. 1992. Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi. Infect. Immun. 60:455.
26. Yang, L., Y. Ma, R. Schoenfeld, M. Griffiths, E. Eichwald, B. Araneo, and J. J. Weis. 1992. Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice. Infect. Immun. 60:3033.
27. Berzofsky, J. A., and I. J. Berkower. 1993. Immunogenicity and antigen structure. In Fundamental Immunology. W. E. Paul, ed. Raven Press, New York, p. 235.
28. Cox, D. L., D. R. Akins, K. W. Bourrel, P. Lahdenne, M. V. Norgard, and J. D. Radolf. 1996. Limited surface exposure of Borrelia burgdorferi outer surface lipoproteins. Proc. Natl. Acad. Sci. USA 93:7973.
29. Kochi, S. K., R. C. Johnson, and A. P. Dalmasso. 1993. Facilitation of complement-dependent killing of the Lyme disease spirochete, Borrelia burgdorferi, by specific immunoglobulin G Fab antibody fragments. Infect. Immun. 61:2532.
30. Marrack, P., and J. Kappler. 1994. Subversion of the immune system by pathogens. Cell 76:323.
31. Garrity, R. R., G. Rimmelzwaan, A. Minassian, W. P. Tsai, G. Lin, J. J. de Jong, J. Goudsmith, and P. L. Nara. 1997. Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope. J. Immunol. 159:279.
32. Kohler, H., J. Goudsmith, and P. Nara. 1992. Clonal dominance: cause for a limited and failing immune response to HIV-1 infection and vaccination. J. Acquired Immune Defic. Syndr. 5:1158.
33. Metlas, R., and V. Veljkovic. 1995. Does HIV-1 manipulate immune network via gp120 immunoglobulin-like domain involving V3 loop? Vaccine 13:355.
34. Liang, F. T., and M. T. Philipp. 1999. Analysis of the Ab response to invariable regions of VlsE, the variable surface Ag of Borrelia burgdorferi. 1999. Infect. Immun. In press.